Publication:
Comparison of the Algan Hemostatic Agent with Floseal in Rat Liver \rLaceration Bleeding Model

dc.contributor.authorBinnetoğlu, Kenan
dc.contributor.authorÖzbaykuş, Abdullah Canberk
dc.contributor.authorKumandas, Ali
dc.contributor.authorEkici, Hüsamettin
dc.contributor.institutionKafkas Üniversitesi
dc.contributor.institutionBahçeşehir Üniversitesi
dc.contributor.institutionKırıkkale Üniversitesi
dc.contributor.institutionKırıkkale Üniversitesi
dc.date.accessioned2025-09-20T19:56:01Z
dc.date.issued2022
dc.date.submitted24.06.2022
dc.description.abstractObjective: Major vascular injury is one of the most important causes of death after trauma. The effective \rand speedy control of the hemorrhage is crucial in reducing deaths. Many products are used for this purpose. \rToday, however, an ideal product has not yet been produced and there is a strong demand for such effective \rhemostatic products. The aim of this study is to compare the efficacy of Algan hemostatic agent with Floseal \rin the liver laceration model in rats.\rMaterials and Methods: A total of 28 rats were used in the study. Rats were divided into 4 groups, each \rconsisting of 7 rats. Experimental liver laceration was established. In the control group, saline-impregnated \rgauze was applied. Algan hemostatic agent-impregnated sponge, Algan hemostatic agent powder, and Floseal \rgel were applied to the experimental groups.\rResults: There was no difference in bleeding control among the Algan hemostatic agent powder, Algan \rhemostatic agent-impregnated sponge, and Floseal. When compared to the control group, Algan hemostatic \ragent powder, Algan hemostatic agent-impregnated sponge, and Floseal were found to be very effective in \rbleeding control, respectively (P=.001, .012, and .002), in the experimental groups.\rConclusion: This study showed that the properties of both Algan hemostatic agent powder and Algan \rhemostatic agent-impregnated sponge for controlling bleeding are similar to Floseal. Considering other characteristics such as Algan hemostatic agent’s naturalness, easy applicability, and low cost, Algan hemostatic \ragent has been a promising effective hemostatic agent.
dc.identifier.doi10.5152/eurasianjmed.2022.21004
dc.identifier.endpage40
dc.identifier.issn1308-8734
dc.identifier.issn1308-8742
dc.identifier.issue1
dc.identifier.startpage36
dc.identifier.urihttps://hdl.handle.net/20.500.14719/4625
dc.identifier.volume54
dc.language.isoen
dc.relation.journalEurasian Journal of Medicine
dc.subjectTıbbi Araştırmalar Deneysel
dc.subjectGenel ve Dahili Tıp
dc.subjectCerrahi
dc.titleComparison of the Algan Hemostatic Agent with Floseal in Rat Liver \rLaceration Bleeding Model
dc.typeResearch Article
dcterms.references1. Parks RW, Chrysos E, Diamond T. Management of liver trauma. Br J Surg. 1999,86(9):1121-1135. [CrossRef],2. Champion HR, Bellamy RF, Roberts CP, Lep\u0002paniemi A. A profile of combat injury. J Trauma. 2003,54(5):S13-S19. [CrossRef],3. Sauaia A, Moore FA, Moore EE, et al. Epidemiol\u0002ogy of trauma deaths: a reassessment. J Trauma. 1995,38(2):185-193. [CrossRef],4. Wu WC, Trivedi A, Friedmann PD, et al. Asso\u0002ciation between hospital intraoperative blood transfusion practices for surgical blood loss and hospital surgical mortality rates. Ann Surg. 2012,255(4):708-714. [CrossRef],5. Huri E, Akgül KT, Yücel MÖ, Astarcı HM, Üstün H, Germiyanoğlu RC. The second step in vitro trial of Ankaferd® Bloodstopper®: comparison with other hemostatic agents. Turk J Med Sci. 2011,41(1):7-15.,6. Hanks JB, Kjaergard HK, Hollingsbee DA. A com\u0002parison of the haemostatic effect of Vivostat® patient-derived fibrin sealant with oxidised cel\u0002lulose (Surgicel®) in multiple surgical proce\u0002dures. Eur Surg Res. 2003,35(5):439-444. [CrossRef],7. Akarsu C, Kalaycı MU, Yavuz E, et al. Comparison of the hemostatic efficiency of Ankaferd Blood Stopper and fibrin glue on a liver laceration model in rats. TJTES. 2011,17:308-312.,8. Aysan E, Kilic K, Kinaci E, Basak F, Caliskan YK. Efficacy of “aluminium sulphate” in prevention of hepatic parenchymal bleeding. Turk J Surg. 2004,20:147-152.,9. Midi A, Kumandas A, Ekici H. Investigation of the efficacy of Algan hemostatic agent in liver lacera\u0002tion model in rats. EJMO. 2019,3(1):37-42. [CrossRef],10. Satar NYG, Akkoc A, Oktay A, Topal A, Inan K. Evaluation of the hemostatic and histopathologi\u0002cal effects of Ankaferd Blood Stopper in experi\u0002mental liver injury in rats. Blood Coagul Fibrinolysis. 2013,24(5):518-524. [CrossRef],11. Aysan E, Bektas H, Ersoz F, Sari S, Kaygusuz A, Huq GE. Ability of the Ankaferd blood stop\u0002per® to prevent parenchymal bleeding in an experimental hepatic trauma model. Int J Clin Exp Med. 2010,3(3):186-191.,12. Fonouni H, Kashfi A, Majlesara A, et al. Hemo\u0002static efficiency of modern topical sealants: com\u0002parative evaluation after liver resection and splenic laceration in a swine model. J Biomed Mater Res B Appl Biomater. 2018,106(3):1307- 1316. [CrossRef],13. Ramirez MG, Deutsch H, Khanna N, Cheatem D, Yang D, Kuntze E. FloSeal only versus in combina\u0002tion in spine surgery: a comparative, retrospec\u0002tive hospital database evaluation of clinical and healthcare resource outcomes. Hosp Prac (1995). 2018,46(4):189-196. [CrossRef],14. Coenye KE, Bourgain C, Keibl C, Nürnberger S, Griensvenet MV. A qualitative morphological comparison of two haemostatic agents in a por\u0002cine liver trauma model. Surg Sci. 2013,4(08):359-364.,15. Echave M, Oyagüez I, Casado MA. Use of Flo\u0002Seal®, a human gelatine-thrombin matrix seal\u0002ant, in surgery: a systematic review. BMC Surg. 2014,14(1):111. [CrossRef],16. Saif R, Jacob M, Robinson S, et al. Use of fibrin\u0002based sealants and gelatin-matrix hemostats in laparoscopic liver surgery. Surg Laparosc Endosc Percutan Tech. 2011,21(3):131-141. [CrossRef],17. Helito CP, Bonadio MB, Sobrado MF, et al. Com\u0002parison of FloSeal® and tranexamic acid for bleeding control after total knee arthroplasty: a prospective randomized study. Clinics (Sao Paulo). 2019,74:e1186. [CrossRef],18. Beyea JA, Rotenberg BW. Comparison of puri\u0002fied plant polysaccharide (HemoStase) versus gelatin-thrombin matrix (FloSeal) in controlling bleeding during sinus surgery: a randomized con\u0002trolled trial. Ann Otol Rhinol Laryngol. 2011,120(8):495-498. [CrossRef],19. Kınacı E, Basak F, Dincel O. Efficacy of calcium alginate in prevention of hepatic parenchymal bleeding: an experimental study. J Gastroenterol Hepatol. 2013,2(5):593-596.,20. Yasunaga H. Risk of authoritarianism: fibrinogen\u0002transmitted hepatitis C in Japan. Lancet. 2007,370(9604):2063-2067. [CrossRef],21. Schwab PE, Thienpont E. Use of a haemostatic matrix (FloSeal®) does not reduce blood loss in minimally invasive total knee arthroplasty per\u0002formed under continued aspirin. Blood Transfus. 2016,14(2):134-139. [CrossRef],22. Midi A, Kumandaş A, Ekici H. Investigation of the effectiveness of algan hemostatic agent in renal venous bleeding model in rats. EJMI. 2018,2(3):129-132. [CrossRef],23. Midi A, Ekici H, Kumandas A, et al. Investigation of the effectiveness of algan hemostatic agent in bleeding control using an experimental partial splenectomy model in rats. Marmara Med J. 2019,32(1):27-32. [CrossRef],24. Midi A, Ozyurek H, Karahan S, et al. Investigation of efficacy of the plant based algan hemostatic agent in hepatectomy bleeding model in rats. EJMI. 2018,2:195-201. [CrossRef],25. Aksoy H, Sener A, Akakin D, et al. The Effect of algan hemostatic agent (AHA) on wound heal\u0002ing. Clin Exp Health Sci. 2020,10(3):279-284. [CrossRef],26. Gedar Totuk ÖM, Güzel ŞE, Ekici H, et al. Effects of algan hemostatic agent on bleeding time in a rat tail hemorrhage model. Ulus Travma Acil Cer\u0002rahi Derg. 2020,26(6):853-858. [CrossRef],27. Song H, Zhang L, Zhao X. Hemostatic efficacy of biological self‐assembling peptide nanofibers in a rat kidney model. Macromol Biosci. 2010,10(1):33-39. [CrossRef],28. Rhee P, Brown C, Martin M, et al. QuikClot use in trauma for hemorrhage control: case series of 103 documented uses. J Trauma. 2008,64(4):1093- 1099. [CrossRef],29. Kauvar DS, Lefering R, Wade CE. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and ther\u0002apeutic considerations. J Trauma. 2006,60(6):S3- 11. [CrossRef]
dspace.entity.typePublication
local.indexed.atTRDizin

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Comparison of the Algan Hemostatic Agent with Floseal in Rat Liver Laceration Bleeding Model.pdf
Size:
1.73 MB
Format:
Adobe Portable Document Format